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Abstract 
We determined the effects of different dialysis conditions on the antioxidant content, duration of the lag phase and 
oxidation rate of LDL. Dialysis for 22 h resulted in a 56%66% reduction in the concentrations of a-carotene, 
lycopene and a-tocopherol. The lag phase of copper-induced oxidation of freshly isolated LDL was considerably 
longer than that of LDL dialysed for 22 or 44 h. Our data show that dialysis may result in LDL preparations with 
antioxidant compositions that are not truly representative of freshly isolated lipoproteins. 
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1. Introduction 
Several lines of evidence, from both in vitro and 
in vivo studies, suggest that oxidative modifica- 
tion of low density lipoprotein (LDL) may con- 
tribute to atherosclerosis [l-4]. A number of 
assays monitoring the oxidative susceptibility of 
the particle have been developed to evaluate the 
atherogenic potential of LDL [5-71. Most often 
the LDL oxidation is initiated by incubating with 
cultured cells or with transition metal ions as 
pro-oxidants [5]. Esterbauer et al. [8] developed a 
method to assess the susceptibility of LDL to 
copper-mediated oxidation in vitro by continuous 
monitoring of the formation of conjugated dienes. 
The mechanistic aspects of this method were in- 
vestigated recently [9,10]. The in vitro assay of 
conjugated diene formation is widely used to esti- 
mate the resistance of LDL to oxidation (e.g. 
[12- 141). This implies that the isolated LDL 
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should be representative of the circulating LDL 
particles in vivo. 
Unfortunately, ultracentrifugation, the most 
widely used procedure for LDL isolation, is time- 
consuming and preservatives like EDTA are regu- 
larly included in the high-salt solutions to limit 
oxidation. Isolated LDL are often extensively di- 
alysed in order to remove these compounds prior 
to the oxidation assay. In this study we examined 
the effects of this dialysis step on the concentra- 
tion of lipophilic antioxidants in LDL and on the 
parameters of the diene formation during oxida- 
tion of LDL in the presence of Cu2 + . 
2. Methods 
2.1. Subjects 
Nine healthy volunteers (6 males, 3 females) 
participated in the study after informed consent. 
Ages ranged from 25 to 50 years. The average 
plasma total cholesterol level was 5.4 mmol/l 
(range 4.2-5.3 in females and 4.4-6.6 in males). 
These and other characteristics of the study sub- 
jects are given in Table 1. 
2.2. Lipoprotein isolation, preparation and 
oxidation 
Blood samples were obtained, after an overnight 
fast, in EDTA-containing tubes. Plasma was pre- 
pared by centrifugation at 2000 x g for 15 min at 
4°C. The plasma samples were divided into two 
identical aliquots and lipoproteins were separated 
by density gradient ultracentrifugation [151, using 
a Beckman SW40 or SW41 rotor and ultraclear 
centrifuge tubes. After ultracentrifugation, the 
LDL fractions (d = 1.019-1.063 g/ml) were col- 
lected by tube slicing. A part of the freshly isolated 
LDL in 0.1 mM EDTA was immediately used for 
a conjugated diene formation assay [14]. Another 
part was stored immediately at - 80°C under 
nitrogen until analysis of antioxidants. LDL iso- 
lated in 1.0 mM EDTA were dialysed against 
0.01 mM EDTA according to Kleinveld et al. [lo]. 
Three different dialysis methods were used, 
varying in time and/or EDTA concentration. In 
all dialysis procedures 2 ml LDL samples were 
dialysed at 4°C in the dark against a total volume 
of 3 1 of 0.01 M phosphate-buffered saline (PBS, 
pH 7.4). All dialysis solutions were degassed and 
purged with nitrogen prior to use and during 
dialysis. In method A, LDL was dialysed for 22 h 
against PBS containing 0.01 mM EDTA. In meth- 
ods B and C, LDL were dialysed for 44 h against 
PBS with 0.01 mM EDTA (method B) or without 
EDTA (method C). Immediately after dialysis the 
protein content of LDL was determined using 
bovine albumin as the standard [16], and the LDL 
samples were stored at - 8O”C, under nitrogen, 
until antioxidant measurement. 
The formation of conjugated dienes during cop- 
per-mediated oxidation was continuously moni- 
tored at 234 nm in a Hitachi U 2000 UVjVIS 
spectrophotometer. Before the start of the oxida- 
tion experiments using dialysed LDL, samples 
were diluted with PBS to give a final concentra- 
tion in the assay cuvette of 50 ,ug/ml LDL protein 
and 1 PM EDTA. The incubation mixture was 
brought to 30°C and CuCl, was added to a final 
concentration of 5 PM to initiate oxidation. The 
absorbance at 234 nm was monitored at 2 min 
intervals and the lag phase before conjugated 
diene formation occurred, as well as the maxi- 
mum rate of oxidation and the maximal amount 
of conjugated dienes, was calculated from the 
oxidation profile [8]. When dialysis was omitted, 
LDL samples were diluted with 1.18 M NaCl 
containing 0.1 mM EDTA, immediately after 
lipoprotein isolation. This ensured that the EDTA 
concentration was equal in all samples. CuCl,-me- 
diated oxidation of undialysed LDL was carried 
out according to Princen et al. [14]. Briefly, 50 pug 
of LDL protein was incubated at 30°C in a total 
volume of 1 .O ml PBS containing 50 PM CuCl, 
Table 1 
Characteristics of subjects 
Mean + S.E.M. Range 
Age (years) 37.8 + 2.7 25-50 
BMI (kg/m’) 22.1 + 0.8 18.9-25.0 
Plasma cholesterol (mM) 5.42 + 0.82 4.14-6.64 
Plasma TAG (mM) 1.08 k 0.28 0.71-1.50 
p-carotene (mg/l) 0.33 * 0.13 0.11-0.57 
Lycopene (mg/l) 0.24kO.12 0.09-0.52 
cc-tocopherol (mg/l) 11.21 f 2.23 8.34-14.80 
Data represent he mean of 9 individuals. BMI, body mass 
index; TAG, triacylglycerol. 
Table 2 
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Effect of dialysis on lipid-soluble antioxidants in LDL (pg per mg LDL protein) 
No dialysis 22 h + EDTA 44 h+EDTA 44 h-EDTA 
a-tocopherol 6.49 + 0.50” 2.19 k 0.31 3.00 + 0.31 2.46 + 0.31 
a-carotene 0.36 k 0.04” 0.16 k 0.04 0.19+0.02 0.13 * 0.03 
Lycopene 0.26 k 0.05” 0.09 * 0.02 0.12 kO.03 0.04 + 0.01 
Data represent he mean + S.E.M. (n = 9). 
“Significantly different from dialysed LDL, P < 0.001 
and conjugated diene formation was monitored at 
234 nm. The final EDTA concentration was 25 
PM. 
2.3. Analytical procedures 
The concentrations of a-carotene, lycopene and 
a-tocopherol were determined in plasma and 
LDL as follows. LDL or plasma samples were 
extracted with n-heptane containing 6-tocopherol 
and ethyl-/?-apo-8’-carotenoate as internal stan- 
dards. Lipid soluble antioxidants were determined 
by HPLC using an ET 200/8/4 nucleosil 5CN 
column (250 x 4 mm, Mackery and Nagel) and 
n-heptane-chloroform-2-propanol (100: 1.50.15, 
v/v) as the mobile phase. The eluent was moni- 
tored with a WjVIS detector set at 292 nm 
(cr-tocopherol), 298 nm (6-tocopherol) and 450 
nm (carotenoids). 
Total cholesterol and triacylglycerol in plasma 
and lipoprotein fractions were measured by 
standard enzymatic procedures (Boehringer, 
Mannheim, Germany) on a Cobas Mira S ana- 
lyzer. Malondialdehyde (MDA) in LDL was de- 
termined by HPLC analysis after complexation 
with diethyl barbituric acid essentially as de- 
scribed by Wong et al. [ 171. Lipoperoxides in 
LDL were measured with a iodometric assay [ 181. 
2.4. Statistical analysis 
Results are expressed as the mean ) S.E.M. 
(n = 9). Statistical analysis was performed with 
the SAS statistical package. Data were analysed 
by one way ANOVA. Multiple comparisons be- 
tween means were carried out using the Tukey 
test. 
3. Results and discussion 
In the present study we examined the effect of 
dialysis on the antioxidant content of LDL and on 
the susceptibility of LDL to copper-initiated oxida- 
tion. The data shown in Table 2 clearly indicate that 
dialysis of LDL resulted in a significant loss of 
a-tocopherol, the major lipophilic antioxidant in 
LDL. After 22 h of dialysis, in the presence of 0.01 
mM EDTA, the concentration of a-tocopherol was 
decreased by approximately 66%. Prolonged dialy- 
sis for up to 44 h, in either the presence or absence 
of EDTA, did not further decrease LDL a-toco- 
pherol levels. Analysis of a-tocopherol in all lipo- 
protein fractions gave a recovery of approximately 
100% (not shown). The loss of p-carotene and 
lycopene from the LDL particle was comparable to 
that of a-tocopherol (Table 2). 
It was reported previously that, in LDL subjec- 
ted to copper-mediated oxidation, depletion of lipo- 
philic antioxidants precedes the propagation phase 
of the oxidation of polyunsaturated fatty acids [9]. 
This implies that the dialysis-induced loss of fat-sol- 
uble antioxidants may significantly affect the lag 
phase of oxidised LDL. To allow direct measure- 
ment of the oxidation of freshly isolated LDL in the 
presence of EDTA (25 ,uM), we determined the 
optimal copper concentration in the assay mixture. 
The optimum was found to be 50 ,uM, close to the 
40 ,uM reported by Princen et al. [14]. 
The optimal CuCl, concentration for the oxida- 
tion of dialysed LDL particles in the presence of 1 
,uM EDTA at protein concentration of 50 pg/ml 
was determined to be 5 PM. This agrees with 
published data [lo], although there is ongoing 
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discussion on the precise optimal molar ratio of 
Cu*+/LDL [ll]. The results presented in Fig. 1 
demonstrate that dialysis of LDL for 22 or 
44 h in the presence of 0.01 mM EDTA signifi- 
cantly decreased the lag phase (P < 0.001) 
compared with undialysed LDL. Omission of 
EDTA in the dialysis buffer did not result in a 
further decrease of the lag time observed after 
44 h of dialysis. Neither the maximal rate of 
oxidation (Fig. 1) nor the maximal amount of 
conjugated dienes formed during oxidation was 
profoundly changed after dialysis. The maxi- 
mal rate of oxidation was increased by about 
25% after 44 h dialysis in the presence of 
EDTA. The reason for this increase is not clear 
at present. 
As an estimation of the lipid peroxidation of 
polyunsaturated fatty acids during dialysis, we 
measured the level of MDA in LDL before and 
after dialysis. Freshly isolated LDL contained 
1.04 + 0.35 nmol MDA per mg protein. This 
value was virtually unchanged after 22 h of dial- 
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ysis (1.34 f 0.17 nmol/mg). After dialysis for 
44 h in the presence of EDTA the level of MDA 
tended to increase (2.02 f 0.29), while after 44 
h in the absence of EDTA, MDA levels in LDL 
were significantly increased compared with the 
other dialysis conditions (3.19 + 0.28 nmol/mg 
protein, P < 0.001). The lipoperoxide levels in 
the same LDL preparations were 42 + 2, 82 _+ 
5, 95 ) 3 and 372 f 68 nmol per mg LDL 
protein, respectively. Again the latter values are 
significantly increased compared with the other 
conditions (P < 0.001). Fig. 2 illustrates our 
findings on MDA and lipoperoxide contents of 
freshly isolated and dialysed LDL. 
It must be kept in mind that not all lipophilic 
antioxidants present in plasma are exclusively 
present in LDL. Freshly isolated VLDL, LDL 
and HDL of our study subjects contained 13 f 
6%, 45 + 5% and 30 + 7% of total plasma 
a-tocopherol, respectively. The remaining 12 + 
2% was located in the lipoprotein deficient 
plasma fraction of density > 1.21 g/ml. So both 
700 
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44 h+EDTA 
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Total dimes 
Fig. 1. Bar diagram showing lag phase before conjugated diene formation, the maximum oxidation rate and the maximal amount 
of dienes formed in copper-oxidised LDL which were not dialysed; dialysed for 22 h in the presence of EDTA (method A); dialysed 
for 44 h in the presence of EDTA (method B) or dialysed for 44 h in the absence of EDTA (method C). Values represent he mean 
k S.E.M. of LDL samples from 9 subjects, *No dialysis significantly different from all dialysis groups, P < 0.001. **Significantly 
different from no dialysis, P -C 0.01. 
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Fig. 2. The effect of different dialysis conditions on the concen- 
tration of malondialdehyde (A) and lipoperoxides (B) in LDL. 
LDL were not dialysed (hatched bars); dialysed for 22 h in the 
presence of EDTA (method A, open bars); dialysed for 44 h in 
the presence of EDTA (method B, double hatched bars) or di- 
alysed for 44 h in the absence of EDTA (method C, closed bars). 
Values represent he mean k S.E.M. of LDL samples from 9 
subjects. *Significantly different from no dialysis. P < 0.001. 
LDL and HDL are major carriers of a-tocopherol 
in normolipidemic plasma. Expressed on a choles- 
terol basis LDL and HDL have 1.8 f 0.3 and 3.3 
+ 0.4 pg a-tocopherol/pmol cholesterol, respec- 
tively. It is conceivable that a-tocopherol or other 
antioxidants from HDL may help to prevent LDL 
oxidation under in vivo conditions. 
In summary, our data clearly show that dialysis 
of LDL results in a depletion of lipophilic antiox- 
idants and in a decrease in the lag phase of 
copper-initiated oxidation of LDL particles. An- 
tioxidants such as ubiquinol-10, not measured in 
the present study, could also be affected by dialy- 
sis. It can be concluded that dialysis may result in 
LDL particles that are not truly representative of 
freshly isolated lipoproteins. Future research 
should be directed towards the development of 
highly controlled, rapid procedures for LDL iso- 
lation. Our data show that it may be prudent not 
to submit LDL to prolonged dialysis. Recently 
F’uhl et al. [l l] have proposed gelfiltration as the 
standard procedure for removal of salts from 
LDL samples. 
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